{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3\u2019,5\u2019-diprenylated chalcone", "PKC\u03b4", "apoptosis", "crosstalk", "pyroptosis"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "32427575", "DateCompleted": {"Year": "2021", "Month": "08", "Day": "02"}, "DateRevised": {"Year": "2021", "Month": "08", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2020", "Month": "05", "Day": "19"}], "Language": ["eng"], "ELocationID": ["10.18632/aging.103178"], "Journal": {"ISSN": "1945-4589", "JournalIssue": {"Volume": "12", "Issue": "10", "PubDate": {"Year": "2020", "Month": "May", "Day": "19"}}, "Title": "Aging", "ISOAbbreviation": "Aging (Albany NY)"}, "ArticleTitle": "A novel 3',5'-diprenylated chalcone induces concurrent apoptosis and GSDME-dependent pyroptosis through activating PKC\u03b4/JNK signal in prostate cancer.", "Pagination": {"StartPage": "9103", "EndPage": "9124", "MedlinePgn": "9103-9124"}, "Abstract": {"AbstractText": ["Although androgen deprivation therapy may initially be effective in prostate cancer, the disease can gradually progress to castration-resistant prostate cancer, at which point chemotherapy becomes the major clinical strategy. In this study, we demonstrated the anti-cancer potential of a novel 3',5'-diprenylated chalcone (C10), which selectively inhibited the proliferation of PC3 cells <i>in vitro</i> and <i>in vivo</i>. C10 treatment elevated the proportion of PC3 cells in sub-G1 phase and induced programmed cell death. Interestingly, C10 elicited concurrent Caspase-dependent apoptotic and gasdermin E-dependent pyroptotic events. RNA-Seq and bioinformatics analyses revealed a strong correlation between protein kinase C delta (PKC\u03b4) and mitogen-activated protein kinase pathway activation in prostate cancer. PKC\u03b4 silencing in PC3 cells suppressed the activation of the JNK pathway and the expression of its downstream genes, including Bax, interleukin-6 and interleukin-1\u03b2, which are involved in apoptotic and pyroptotic processes. Moreover, in PC3 cell xenograft tumor tissues, C10 treatment inhibited tumor growth and upregulated PKC\u03b4. These findings suggest that C10 treatment induces the PKC\u03b4/JNK pathway, thereby activating Caspase-3 and inducing the cleavage of PARP and gasdermin E to execute apoptosis and cell-lytic pyroptosis in prostate cancer cells."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, P.R. China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial People's Hospital, Guiyang 550002, P.R. China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, P.R. China."}], "LastName": "Zhang", "ForeName": "Yongqiang", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, P.R. China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, P.R. China."}], "LastName": "Yang", "ForeName": "Jue", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, P.R. China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, P.R. China."}], "LastName": "Wen", "ForeName": "Zhonghang", "Initials": "Z"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial People's Hospital, Guiyang 550002, P.R. China."}], "LastName": "Chen", "ForeName": "Xiaoyue", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, P.R. China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, P.R. China."}], "LastName": "Yu", "ForeName": "Jia", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Guizhou Provincial People's Hospital, Guiyang 550002, P.R. China."}], "LastName": "Yuan", "ForeName": "Dongbo", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, P.R. China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, P.R. China."}], "LastName": "Xu", "ForeName": "Bixue", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, P.R. China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, P.R. China."}], "LastName": "Luo", "ForeName": "Heng", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang 550014, P.R. China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial People's Hospital, Guiyang 550002, P.R. China."}, {"Identifier": [], "Affiliation": "Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academy of Sciences, Guiyang 550014, P.R. China."}], "LastName": "Zhu", "ForeName": "Jianguo", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Aging (Albany NY)", "NlmUniqueID": "101508617", "ISSNLinking": "1945-4589"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Chalcones"}, {"RegistryNumber": "0", "NameOfSubstance": "GSDMD protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Intracellular Signaling Peptides and Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Phosphate-Binding Proteins"}, {"RegistryNumber": "EC 2.7.11.13", "NameOfSubstance": "Protein Kinase C-delta"}, {"RegistryNumber": "EC 2.7.12.2", "NameOfSubstance": "MAP Kinase Kinase 4"}], "MeshHeadingList": [{"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Survival"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Chalcones"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism"], "DescriptorName": "Intracellular Signaling Peptides and Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "MAP Kinase Kinase 4"}, {"QualifierName": ["drug effects"], "DescriptorName": "MAP Kinase Signaling System"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["metabolism"], "DescriptorName": "Phosphate-Binding Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "Prostatic Neoplasms"}, {"QualifierName": ["metabolism"], "DescriptorName": "Protein Kinase C-delta"}, {"QualifierName": ["drug effects"], "DescriptorName": "Pyroptosis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Transcriptome"}], "CoiStatement": "<b>CONFLICTS OF INTEREST:</b> The authors declare that they have no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018; 68:7\u201330. 10.3322/caac.21442", "ArticleIdList": ["10.3322/caac.21442", "29313949"]}, {"Citation": "Yap TA, Smith AD, Ferraldeschi R, Al-Lazikani B, Workman P, de Bono JS. Drug discovery in advanced prostate cancer: translating biology into therapy. Nat Rev Drug Discov. 2016; 15:699\u2013718. 10.1038/nrd.2016.120", "ArticleIdList": ["10.1038/nrd.2016.120", "27444228"]}, {"Citation": "Nevedomskaya E, Baumgart SJ, Haendler B. Recent advances in prostate cancer treatment and drug discovery. Int J Mol Sci. 2018; 19:1359. 10.3390/ijms19051359", "ArticleIdList": ["10.3390/ijms19051359", "PMC5983695", "29734647"]}, {"Citation": "Tucci M, Caffo O, Buttigliero C, Cavaliere C, D\u2019aniello C, Di Maio M, Kinspergher S, Maines F, Rizzo M, Rossetti S, Veccia A, Scagliotti GV, Facchini G. Therapeutic options for first-line metastatic castration-resistant prostate cancer: suggestions for clinical practise in the CHAARTED and LATITUDE era. Cancer Treat Rev. 2019; 74:35\u201342. 10.1016/j.ctrv.2019.01.002", "ArticleIdList": ["10.1016/j.ctrv.2019.01.002", "30738364"]}, {"Citation": "Rogers C, Fernandes-Alnemri T, Mayes L, Alnemri D, Cingolani G, Alnemri ES. Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death. Nat Commun. 2017; 8:14128. 10.1038/ncomms14128", "ArticleIdList": ["10.1038/ncomms14128", "PMC5216131", "28045099"]}, {"Citation": "Wallach D, Kang TB, Dillon CP, Green DR. Programmed necrosis in inflammation: toward identification of the effector molecules. Science. 2016; 352:aaf2154. 10.1126/science.aaf2154", "ArticleIdList": ["10.1126/science.aaf2154", "27034377"]}, {"Citation": "Jiang L, Poon IK. Methods for monitoring the progression of cell death, cell disassembly and cell clearance. Apoptosis. 2019; 24:208\u201320. 10.1007/s10495-018-01511-x", "ArticleIdList": ["10.1007/s10495-018-01511-x", "30684146"]}, {"Citation": "Zhang YQ, Wen ZH, Wan K, Yuan D, Zeng X, Liang G, Zhu J, Xu B, Luo H. A novel synthesized 3\u2019, 5\u2019-diprenylated chalcone mediates the proliferation of human leukemia cells by regulating apoptosis and autophagy pathways. Biomed Pharmacother. 2018; 106:794\u2013804. 10.1016/j.biopha.2018.06.153", "ArticleIdList": ["10.1016/j.biopha.2018.06.153", "29990873"]}, {"Citation": "Lamkanfi M, Dixit VM. Manipulation of host cell death pathways during microbial infections. Cell Host Microbe. 2010; 8:44\u201354. 10.1016/j.chom.2010.06.007", "ArticleIdList": ["10.1016/j.chom.2010.06.007", "20638641"]}, {"Citation": "Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol. 2014; 15:49\u201363. 10.1038/nrm3722", "ArticleIdList": ["10.1038/nrm3722", "24355989"]}, {"Citation": "Lam M, Lawrence DA, Ashkenazi A, Walter P. Confirming a critical role for death receptor 5 and caspase-8 in apoptosis induction by endoplasmic reticulum stress. Cell Death Differ. 2018; 25:1530\u201331. 10.1038/s41418-018-0155-y", "ArticleIdList": ["10.1038/s41418-018-0155-y", "PMC6113221", "29991746"]}, {"Citation": "Lopez J, Tait SW. Mitochondrial apoptosis: killing cancer using the enemy within. Br J Cancer. 2015; 112:957\u201362. 10.1038/bjc.2015.85", "ArticleIdList": ["10.1038/bjc.2015.85", "PMC4366906", "25742467"]}, {"Citation": "Shakeri R, Kheirollahi A, Davoodi J. Apaf-1: regulation and function in cell death. Biochimie. 2017; 135:111\u201325. 10.1016/j.biochi.2017.02.001", "ArticleIdList": ["10.1016/j.biochi.2017.02.001", "28192157"]}, {"Citation": "Kumar S, Calianese D, Birge RB. Efferocytosis of dying cells differentially modulate immunological outcomes in tumor microenvironment. Immunol Rev. 2017; 280:149\u201364. 10.1111/imr.12587", "ArticleIdList": ["10.1111/imr.12587", "PMC8359679", "29027226"]}, {"Citation": "Ding J, Wang K, Liu W, She Y, Sun Q, Shi J, Sun H, Wang DC, Shao F. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016; 535:111\u201316. 10.1038/nature18590", "ArticleIdList": ["10.1038/nature18590", "27281216"]}, {"Citation": "Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, Lieberman J. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016; 535:153\u201358. 10.1038/nature18629", "ArticleIdList": ["10.1038/nature18629", "PMC5539988", "27383986"]}, {"Citation": "Boucher D, Monteleone M, Coll RC, Chen KW, Ross CM, Teo JL, Gomez GA, Holley CL, Bierschenk D, Stacey KJ, Yap AS, Bezbradica JS, Schroder K. Caspase-1 self-cleavage is an intrinsic mechanism to terminate inflammasome activity. J Exp Med. 2018; 215:827\u201340. 10.1084/jem.20172222", "ArticleIdList": ["10.1084/jem.20172222", "PMC5839769", "29432122"]}, {"Citation": "Robinson N, Ganesan R, Heged\u0171s C, Kov\u00e1cs K, Kufer TA, Vir\u00e1g L. Programmed necrotic cell death of macrophages: focus on pyroptosis, necroptosis, and parthanatos. Redox Biol. 2019; 26:101239. 10.1016/j.redox.2019.101239", "ArticleIdList": ["10.1016/j.redox.2019.101239", "PMC6582207", "31212216"]}, {"Citation": "Conos SA, Chen KW, De Nardo D, Hara H, Whitehead L, N\u00fa\u00f1ez G, Masters SL, Murphy JM, Schroder K, Vaux DL, Lawlor KE, Lindqvist LM, Vince JE. Active MLKL triggers the NLRP3 inflammasome in a cell-intrinsic manner. Proc Natl Acad Sci USA. 2017; 114:E961\u2013E969. 10.1073/pnas.1613305114", "ArticleIdList": ["10.1073/pnas.1613305114", "PMC5307433", "28096356"]}, {"Citation": "Wang Y, Gao W, Shi X, Ding J, Liu W, He H, Wang K, Shao F. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017; 547:99\u2013103. 10.1038/nature22393", "ArticleIdList": ["10.1038/nature22393", "28459430"]}, {"Citation": "Rogers C, Erkes DA, Nardone A, Aplin AE, Fernandes-Alnemri T, Alnemri ES. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat Commun. 2019; 10:1689. 10.1038/s41467-019-09397-2", "ArticleIdList": ["10.1038/s41467-019-09397-2", "PMC6459836", "30976076"]}, {"Citation": "Newton AC. Protein kinase C as a tumor suppressor. Semin Cancer Biol. 2018; 48:18\u201326. 10.1016/j.semcancer.2017.04.017", "ArticleIdList": ["10.1016/j.semcancer.2017.04.017", "PMC5668200", "28476658"]}, {"Citation": "Nishizuka Y. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature. 1984; 308:693\u201398. 10.1038/308693a0", "ArticleIdList": ["10.1038/308693a0", "6232463"]}, {"Citation": "Rosse C, Linch M, Kermorgant S, Cameron AJ, Boeckeler K, Parker PJ. PKC and the control of localized signal dynamics. Nat Rev Mol Cell Biol. 2010; 11:103\u201312. 10.1038/nrm2847", "ArticleIdList": ["10.1038/nrm2847", "20094051"]}, {"Citation": "Scotti ML, Bamlet WR, Smyrk TC, Fields AP, Murray NR. Protein kinase ciota is required for pancreatic cancer cell transformed growth and tumorigenesis. Cancer Res. 2010; 70:2064\u201374. 10.1158/0008-5472.CAN-09-2684", "ArticleIdList": ["10.1158/0008-5472.CAN-09-2684", "PMC2881466", "20179210"]}, {"Citation": "Castilla C, Chinch\u00f3n D, Medina R, Torrubia FJ, Jap\u00f3n MA, S\u00e1ez C. PTPL1 and PKC\u03b4 contribute to proapoptotic signalling in prostate cancer cells. Cell Death Dis. 2013; 4:e576. 10.1038/cddis.2013.90", "ArticleIdList": ["10.1038/cddis.2013.90", "PMC3668626", "23559010"]}, {"Citation": "Du Y, Zhao Y, Li C, Zheng Q, Tian J, Li Z, Huang TY, Zhang W, Xu H. Inhibition of PKC\u03b4 reduces amyloid-\u03b2 levels and reverses alzheimer disease phenotypes. J Exp Med. 2018; 215:1665\u201377. 10.1084/jem.20171193", "ArticleIdList": ["10.1084/jem.20171193", "PMC5987914", "29739836"]}, {"Citation": "Liu T, Yao Y, Zhang G, Wang Y, Deng B, Song J, Li X, Han F, Xiao X, Yang J, Xia L, Li YJ, Plachynta M, et al.. A screen for fli-1 transcriptional modulators identifies PKC agonists that induce erythroid to megakaryocytic differentiation and suppress leukemogenesis. Oncotarget. 2017; 8:16728\u201343. 10.18632/oncotarget.14377", "ArticleIdList": ["10.18632/oncotarget.14377", "PMC5369997", "28052010"]}, {"Citation": "Zhuang C, Zhang W, Sheng C, Zhang W, Xing C, Miao Z. Chalcone: a privileged structure in medicinal chemistry. Chem Rev. 2017; 117:7762\u2013810. 10.1021/acs.chemrev.7b00020", "ArticleIdList": ["10.1021/acs.chemrev.7b00020", "PMC6131713", "28488435"]}, {"Citation": "Wen Z, Zhang Y, Wang X, Zeng X, Hu Z, Liu Y, Xie Y, Liang G, Zhu J, Luo H, Xu B. Novel 3\u2019,5\u2019-diprenylated chalcones inhibited the proliferation of cancer cells in vitro by inducing cell apoptosis and arresting cell cycle phase. Eur J Med Chem. 2017; 133:227\u201339. 10.1016/j.ejmech.2017.03.077", "ArticleIdList": ["10.1016/j.ejmech.2017.03.077", "28390228"]}, {"Citation": "Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015; 14:111\u201329. 10.1038/nrd4510", "ArticleIdList": ["10.1038/nrd4510", "25614221"]}, {"Citation": "White NJ. Qinghaosu (artemisinin): the price of success. Science. 2008; 320:330\u201334. 10.1126/science.1155165", "ArticleIdList": ["10.1126/science.1155165", "18420924"]}, {"Citation": "Su XZ, Miller LH. The discovery of artemisinin and the nobel prize in physiology or medicine. Sci China Life Sci. 2015; 58:1175\u201379. 10.1007/s11427-015-4948-7", "ArticleIdList": ["10.1007/s11427-015-4948-7", "PMC4966551", "26481135"]}, {"Citation": "Jandial DD, Blair CA, Zhang S, Krill LS, Zhang YB, Zi X. Molecular targeted approaches to cancer therapy and prevention using chalcones. Curr Cancer Drug Targets. 2014; 14:181\u2013200. 10.2174/1568009614666140122160515", "ArticleIdList": ["10.2174/1568009614666140122160515", "PMC4107204", "24467530"]}, {"Citation": "Greaves M. Evolutionary determinants of cancer. Cancer Discov. 2015; 5:806\u201320. 10.1158/2159-8290.CD-15-0439", "ArticleIdList": ["10.1158/2159-8290.CD-15-0439", "PMC4539576", "26193902"]}, {"Citation": "Workman P, Al-Lazikani B, Clarke PA. Genome-based cancer therapeutics: targets, kinase drug resistance and future strategies for precision oncology. Curr Opin Pharmacol. 2013; 13:486\u201396. 10.1016/j.coph.2013.06.004", "ArticleIdList": ["10.1016/j.coph.2013.06.004", "23810823"]}, {"Citation": "Syed YY. Anlotinib: first global approval. Drugs. 2018; 78:1057\u201362. 10.1007/s40265-018-0939-x", "ArticleIdList": ["10.1007/s40265-018-0939-x", "29943374"]}, {"Citation": "Gurbuz N, Park MA, Dent P, Abdel Mageed AB, Sikka SC, Baykal A. Cystine dimethyl ester induces apoptosis through regulation of PKC-\u03b4 and PKC-\u03b5 in prostate cancer cells. Anticancer Agents Med Chem. 2015; 15:217\u201327. 10.2174/1871520614666141120121901", "ArticleIdList": ["10.2174/1871520614666141120121901", "25410184"]}, {"Citation": "Zhang P, Goodrich C, Fu C, Dong C. Melanoma upregulates ICAM-1 expression on endothelial cells through engagement of tumor CD44 with endothelial E-selectin and activation of a PKC\u03b1-p38-SP-1 pathway. FASEB J. 2014; 28:4591\u2013609. 10.1096/fj.11-202747", "ArticleIdList": ["10.1096/fj.11-202747", "PMC4200333", "25138157"]}, {"Citation": "Villar J, Arenas MI, MacCarthy CM, Bl\u00e1nquez MJ, Tirado OM, Notario V. PCPH/ENTPD5 expression enhances the invasiveness of human prostate cancer cells by a protein kinase C delta-dependent mechanism. Cancer Res. 2007; 67:10859\u201368. 10.1158/0008-5472.CAN-07-2041", "ArticleIdList": ["10.1158/0008-5472.CAN-07-2041", "18006831"]}, {"Citation": "Xiao L, Gonzalez-Guerrico A, Kazanietz MG. PKC-mediated secretion of death factors in LNCaP prostate cancer cells is regulated by androgens. Mol Carcinog. 2009; 48:187\u201395. 10.1002/mc.20476", "ArticleIdList": ["10.1002/mc.20476", "PMC3113613", "18756441"]}, {"Citation": "Daurio NA, Tuttle SW, Worth AJ, Song EY, Davis JM, Snyder NW, Blair IA, Koumenis C. AMPK activation and metabolic reprogramming by tamoxifen through estrogen receptor-independent mechanisms suggests new uses for this therapeutic modality in cancer treatment. Cancer Res. 2016; 76:3295\u2013306. 10.1158/0008-5472.CAN-15-2197", "ArticleIdList": ["10.1158/0008-5472.CAN-15-2197", "PMC4895922", "27020861"]}, {"Citation": "Roddie HG, Armitage EL, Coates JA, Johnston SA, Evans IR. Simu-dependent clearance of dying cells regulates macrophage function and inflammation resolution. PLoS Biol. 2019; 17:e2006741. 10.1371/journal.pbio.2006741", "ArticleIdList": ["10.1371/journal.pbio.2006741", "PMC6516643", "31086359"]}, {"Citation": "Tsuchiya K, Nakajima S, Hosojima S, Thi Nguyen D, Hattori T, Manh Le T, Hori O, Mahib MR, Yamaguchi Y, Miura M, Kinoshita T, Kushiyama H, Sakurai M, et al.. Caspase-1 initiates apoptosis in the absence of gasdermin D. Nat Commun. 2019; 10:2091. 10.1038/s41467-019-09753-2", "ArticleIdList": ["10.1038/s41467-019-09753-2", "PMC6505044", "31064994"]}]}], "History": [{"Year": "2019", "Month": "10", "Day": "7"}, {"Year": "2020", "Month": "4", "Day": "16"}, {"Year": "2020", "Month": "5", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "20", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "31"}], "PublicationStatus": "ppublish", "ArticleIdList": ["32427575", "PMC7288973", "10.18632/aging.103178", "103178"]}}]}